AM 1172

Pricing Availability   Qty
Cat.No. 3381 - AM 1172 | C27H39NO2 | CAS No. 251908-92-6
Description: Anandamide uptake inhibitor; also FAAH inhibitor and CB receptor partial agonist
Chemical Name: N-(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraen-1-yl-4-hydroxybenzamide
Purity: ≥98% (HPLC)
Literature (3)

Biological Activity for AM 1172

AM 1172 is a metabolically stable anandamide uptake inhibitor (IC50 = 2.1 - 2.5 μM) and fatty acid amide hydrolase (FAAH) inhibitor (Ki = 3.18 μM). Inhibits N-arachidonylethanolamine (AEA) accumulation (IC50 = 24 μM) and hydrolysis (Ki = 3 μM), and inhibits N-palmitoylethanolamine (PEA) hydrolysis (IC50 = 36 μM) in cerebellar granule neurons. Also acts as a non-selective cannabinoid receptor partial agonist (EC50 values are 189 and 271 nM at CB2 and CB1 receptors respectively). FABP inhibitor.

Technical Data for AM 1172

M. Wt 409.6
Formula C27H39NO2
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 251908-92-6
PubChem ID 10364179

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for AM 1172

Solubility Soluble in ethanol (supplied pre-dissolved in anhydrous ethanol, 10mg/ml)

References for AM 1172

References are publications that support the biological activity of the product.

Kaczocha et al (2006) Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J.Biol.Chem. 281 9066 PMID: 16461355

Hillard et al (2007) Studies of anandamide accumulation inhibitors in cerebellar granule neurons. J.Mol.Neurosci. 33 18 PMID: 17901541

Fegley et al (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc.Natl.Acad.Sci.USA 101 8756

Deutsch (2016) A personal retrospective: Elevating Anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs). Front.Pharmacol. 7 370 PMID: 27790143

If you know of a relevant reference for AM 1172, please let us know.

View Related Products by Product Action

View all Cannabinoid Transporter Inhibitors

Keywords: AM 1172, AM 1172 supplier, Anandamide, uptake, inhibitors, inhibits, AMT, FAAH, inhibitor, CB, receptors, partial, agonists, cannabinoid, fatty, acid, amide, hydrolase, neurotransmitter, transporters, AM1172, cb2r, cb1r, FABP, FABPs, binding, protein, Cannabinoid, Transporters, Non-selective, Cannabinoids, Fatty, Acid, Amide, Hydrolase, (FAAH), Other, Binding, Proteins, 3381, Tocris Bioscience

Citations for AM 1172

Citations are publications that use Tocris products.

Currently there are no citations for AM 1172. Do you know of a great paper that uses AM 1172 from Tocris? Please let us know.

Reviews for AM 1172

There are currently no reviews for this product. Be the first to review AM 1172 and earn rewards!

Have you used AM 1172?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Pain Research Product Guide

A collection of over 280 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Cannabinoid Receptor Ligands

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.


Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.